Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Filings indexed 1,687 across all filing types
Latest filing 2021-11-04 Annual Report
Country TW Taiwan
Listing TW 1786

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
110年第3季財務報告書 — 202104_1786_AI3.pdf
Annual Report Classification · 100% confidence The document is titled as an individual financial report and auditor's report for the fiscal years 110 and 109 (Taiwan calendar years, corresponding to 2021 and 2020). It contains detailed financial statements including balance sheets, income statements, cash flow statements, equity changes, and extensive notes on accounting policies and audit opinions. The presence of an auditor's report from Ernst & Young and detailed financial data confirms this is a full annual financial report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K). FY 2021
2021-11-04 Chinese
110年第3季財務報告書 — 202104_1786_AI1.pdf
Annual Report Classification · 100% confidence The document is a consolidated financial report for the years 110 and 109 (Taiwanese calendar years), including detailed financial statements such as the consolidated balance sheet, income statement, statement of changes in equity, and cash flow statement. It also contains an auditor's report from Ernst & Young, with an audit opinion and key audit matters. The document includes extensive notes on accounting policies, judgments, and disclosures. The presence of a full audit report and comprehensive financial statements for a full fiscal year indicates this is an Annual Report. The document is lengthy (15,000 characters) and contains substantive financial data, not just an announcement or certification. Therefore, the correct classification is Annual Report (10-K). FY 2021
2021-11-04 Chinese
110年第3季財務報告書 — 202103_1786_AI1.pdf
Regulatory Filings
2021-11-04 Chinese
110年第3季財務報告書 — 202102_1786_AI1.pdf
Regulatory Filings
2021-11-04 Chinese
110年第3季財務報告書 — 202101_1786_AI1.pdf
Regulatory Filings
2021-11-04 Chinese
110年第3季海外子公司投資
Interim / Quarterly Report Classification · 90% confidence The document contains financial data related to investment in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. It references the 110th year third quarter reporting period, indicating it is a quarterly or interim financial report. The content includes substantive financial data and analysis, not just an announcement or certification. The document length is short but contains actual financial figures, so it is not a report publication announcement or regulatory filing. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2021
2021-11-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.